The purpose of the incorporation of this wholly owned subsidiary is to expand the biopharma products business in Europe.

Aurobindo Pharma reported a consolidated revenue increase of 10.6% year-on-year, reaching Rs 8,382 crore in Q4 FY25.

The global Generic Pharmaceuticals Market size is projected to be valued at USD 391.5 billion in 2023 and reach USD 682.9 ...

Aurobindo Pharma share price declined over 3% on Tuesday after the company reported a fire incident at one of its manufacturing facilities in Andhra Pradesh that resulted in certain ancillary ...

Aurobindo Pharma subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Dasatinib Tablets in different ...

Pharma stocks such as Sun Pharma, Aurobindo Pharma, Dr Reddy's Lab, Cipla, Gland Pharma, Zydus Lifesciences and Lupin would be in action on Friday after the US President Donald Trump halted ...

Generic drugmaker Aurobindo Pharma has received order under the Central Goods and Services Tax Act, 2017, asking it to pay GST, interest and a penalty of more than ₹155 crore. Additional ...

Aurobindo Pharma announced on Saturday that its US-based business has signed a licensing arrangement with a global pharmaceutical company for the development of respiratory treatments. Aurobindo ...

Aurobindo Pharma witnessed a nearly 9% surge in consolidated net profit for Q2FY25, reaching Rs 817 crore. This growth was fueled by an 8% rise in consolidated revenue, driven by a strong ...

On Wednesday, Aurobindo Pharma Ltd. told the exchanges that its new injectable plant in Andhra Pradesh has acquired its first product approval from the USFDA. Eugia Steriles, a 100% subsidiary of ...

(Image Credits: Pixabay) Aurobindo Pharma, a key player in the pharmaceutical industry, is focused on improving self-reliance, and growth trajectory and continues to invest in Research ...